Literature DB >> 10201943

Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages.

M R Horton1, S Shapiro, C Bao, C J Lowenstein, P W Noble.   

Abstract

Although the metalloproteinase murine metalloelastase (MME) has been implicated in lung disorders such as emphysema and pulmonary fibrosis, the mechanisms regulating MME expression are unclear. Low m.w. fragments of the extracellular matrix component hyaluronan (HA) that accumulate at sites of lung inflammation are capable of inducing inflammatory gene expression in macrophages (Mphi). The purpose of this study was to examine the effect of HA fragments on the expression of MME in alveolar Mphi. The mouse alveolar Mphi cell line MH-S was stimulated with HA fragments over time, total RNA was isolated, and Northern blot analysis was performed. HA fragments induced MME mRNA in a time-dependent fashion, with maximal levels at 6 h. HA fragments also induced MME protein expression as well as enzyme activity. The induction of MME gene expression was specific for low m.w. HA fragments and dependent upon new protein synthesis; it occurred at the level of gene transcription. We also examined the effect of HA fragments on MME expression in inflammatory alveolar Mphi from bleomycin-injured rat lungs. Although normal rat alveolar Mphi did not express MME mRNA in response to HA fragments, alveolar Mphi from the bleomycin-treated rats responded to HA fragment stimulation by increasing MME mRNA levels. Furthermore, baseline and HA fragment-induced MME gene expression in alveolar Mphi from bleomycin-treated rats was inhibited by IFN-gamma. These data suggest that HA fragments may be an important mechanism for the expression of MME by Mphi in inflammatory lung disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201943

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal.

Authors:  Jonathan D Powell; Maureen R Horton
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Fragments of extracellular matrix as mediators of inflammation.

Authors:  Tracy L Adair-Kirk; Robert M Senior
Journal:  Int J Biochem Cell Biol       Date:  2007-12-24       Impact factor: 5.085

Review 4.  Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; Ben A Falk; Rebecca P Wu; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

5.  Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way.

Authors:  Huan Chen; Mahesh Mahaseth; Yan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

Review 6.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS.

Authors:  Jun Muto; Kenshi Yamasaki; Kristen R Taylor; Richard L Gallo
Journal:  Mol Immunol       Date:  2009-09-24       Impact factor: 4.407

Review 8.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

9.  Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis.

Authors:  Yasuhide Morioka; Kenshi Yamasaki; Donald Leung; Richard L Gallo
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Potential therapeutic applications of hyaluronan in the lung.

Authors:  Jerome O Cantor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.